| cellular response to follicle stimulating hormone stimulus | GO:0071372 | 13 | 0.997 | |
| inactivation of mapk activity | GO:0000188 | 2 | 0.996 | |
| conditioned taste aversion | GO:0001661 | 2 | 0.994 | |
| regulation of rna biosynthetic process | GO:2001141 | 381 | 0.985 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 33 | 0.975 | |
| collateral sprouting | GO:0048668 | 2 | 0.966 | |
| rna metabolic process | GO:0016070 | 406 | 0.937 | |
| response to camp | GO:0051591 | 91 | 0.923 | |
| regulation of rna metabolic process | GO:0051252 | 391 | 0.916 | |
| cellular response to mycophenolic acid | GO:0071506 | 2 | 0.900 | |
| nucleic acid templated transcription | GO:0097659 | 379 | 0.898 | |
| regulation of transcription from rna polymerase ii promoter | GO:0006357 | 234 | 0.878 | |
| positive regulation of transcription from rna polymerase ii promoter | GO:0045944 | 148 | 0.875 | |
| rna biosynthetic process | GO:0032774 | 380 | 0.871 | |
| regulation of transcription dna templated | GO:0006355 | 374 | 0.869 | |
| positive regulation of rna metabolic process | GO:0051254 | 203 | 0.839 | Human |
| negative regulation of nervous system development | GO:0051961 | 79 | 0.819 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 75 | 0.812 | |
| bmp signaling pathway | GO:0030509 | 4 | 0.811 | |
| transcription dna templated | GO:0006351 | 377 | 0.793 | |
| regulation of nucleic acid templated transcription | GO:1903506 | 380 | 0.784 | |
| positive regulation of g0 to g1 transition | GO:0070318 | 2 | 0.782 | |
| cell proliferation involved in metanephros development | GO:0072203 | 2 | 0.706 | |
| negative regulation of rna metabolic process | GO:0051253 | 123 | 0.705 | |
| negative regulation of cellular macromolecule biosynthetic process | GO:2000113 | 141 | 0.694 | |
| cellular response to hormone stimulus | GO:0032870 | 247 | 0.683 | |
| positive regulation of cell death | GO:0010942 | 184 | 0.658 | |
| apoptotic process | GO:0006915 | 381 | 0.646 | |
| negative regulation of transcription dna templated | GO:0045892 | 116 | 0.634 | |
| cell proliferation involved in kidney development | GO:0072111 | 5 | 0.633 | |
| positive regulation of transcription dna templated | GO:0045893 | 197 | 0.632 | |
| response to purine containing compound | GO:0014074 | 126 | 0.632 | |
| negative regulation of macromolecule biosynthetic process | GO:0010558 | 148 | 0.629 | |
| positive regulation of glomerular mesangial cell proliferation | GO:0072126 | 4 | 0.625 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 27 | 0.616 | |
| oligodendrocyte differentiation | GO:0048709 | 32 | 0.606 | |
| positive regulation of mrna catabolic process | GO:0061014 | 2 | 0.600 | Human |
| regulation of cellular protein metabolic process | GO:0032268 | 267 | 0.587 | Human |
| transcription from rna polymerase ii promoter | GO:0006366 | 252 | 0.584 | |
| skeletal muscle cell differentiation | GO:0035914 | 2 | 0.561 | |
| negative regulation of macromolecule metabolic process | GO:0010605 | 260 | 0.532 | |
| regulation of multicellular organismal development | GO:2000026 | 376 | 0.478 | |
| response to peptide | GO:1901652 | 292 | 0.467 | |
| positive regulation of programmed cell death | GO:0043068 | 157 | 0.450 | |
| regulation of molecular function | GO:0065009 | 398 | 0.450 | |
| regulation of protein metabolic process | GO:0051246 | 289 | 0.449 | Human |
| regulation of protein serine threonine kinase activity | GO:0071900 | 64 | 0.447 | |
| cell projection morphogenesis | GO:0048858 | 123 | 0.439 | |
| circulatory system development | GO:0072359 | 134 | 0.433 | |
| positive regulation of nucleic acid templated transcription | GO:1903508 | 197 | 0.424 | |
| response to organophosphorus | GO:0046683 | 102 | 0.408 | |
| interleukin 1 mediated signaling pathway | GO:0070498 | 2 | 0.403 | |
| response to catecholamine | GO:0071869 | 16 | 0.402 | |
| negative regulation of nucleic acid templated transcription | GO:1903507 | 117 | 0.394 | |
| synaptic growth at neuromuscular junction | GO:0051124 | 1 | 0.393 | |
| myeloid leukocyte differentiation | GO:0002573 | 20 | 0.393 | |
| negative regulation of metabolic process | GO:0009892 | 331 | 0.386 | |
| glomerular mesangium development | GO:0072109 | 4 | 0.383 | |
| regulation of mrna 3 end processing | GO:0031440 | 1 | 0.382 | Human |
| locomotor rhythm | GO:0045475 | 1 | 0.381 | |
| cellular response to gonadotropin stimulus | GO:0071371 | 17 | 0.379 | |
| programmed cell death | GO:0012501 | 392 | 0.376 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 116 | 0.376 | |
| positive regulation of nitrogen compound metabolic process | GO:0051173 | 334 | 0.375 | Human |
| positive regulation of multicellular organismal process | GO:0051240 | 387 | 0.365 | |
| cellular response to cycloheximide | GO:0071409 | 4 | 0.362 | |
| negative regulation of cellular biosynthetic process | GO:0031327 | 161 | 0.359 | |
| positive regulation of apoptotic process | GO:0043065 | 154 | 0.336 | |
| response to extracellular stimulus | GO:0009991 | 380 | 0.335 | |
| tissue development | GO:0009888 | 252 | 0.331 | |
| behavior | GO:0007610 | 205 | 0.323 | |
| negative regulation of cellular metabolic process | GO:0031324 | 281 | 0.322 | |
| cellular response to stress | GO:0033554 | 269 | 0.320 | Human |
| positive regulation of nucleobase containing compound metabolic process | GO:0045935 | 319 | 0.314 | Human |
| negative regulation of nitrogen compound metabolic process | GO:0051172 | 161 | 0.311 | |
| motor neuron axon guidance | GO:0008045 | 1 | 0.305 | |
| positive regulation of biosynthetic process | GO:0009891 | 319 | 0.301 | |
| negative regulation of oligodendrocyte differentiation | GO:0048715 | 3 | 0.300 | |
| positive regulation of rna biosynthetic process | GO:1902680 | 197 | 0.299 | |
| cellular response to endogenous stimulus | GO:0071495 | 377 | 0.298 | |
| negative regulation of rna biosynthetic process | GO:1902679 | 118 | 0.295 | |
| regulation of apoptotic process | GO:0042981 | 335 | 0.293 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 80 | 0.290 | |
| response to hydrogen peroxide | GO:0042542 | 89 | 0.285 | |
| negative regulation of programmed cell death | GO:0043069 | 183 | 0.283 | |
| muscle tissue development | GO:0060537 | 58 | 0.282 | |
| regulation of protein kinase activity | GO:0045859 | 105 | 0.280 | |
| response to corticosterone | GO:0051412 | 40 | 0.274 | |
| response to acid chemical | GO:0001101 | 222 | 0.273 | |
| cellular response to lipid | GO:0071396 | 201 | 0.273 | |
| response to light stimulus | GO:0009416 | 52 | 0.268 | |
| glomerular mesangial cell proliferation | GO:0072110 | 4 | 0.267 | |
| regulation of catalytic activity | GO:0050790 | 304 | 0.257 | |
| response to growth factor | GO:0070848 | 189 | 0.256 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 32 | 0.252 | |
| negative regulation of cell death | GO:0060548 | 229 | 0.252 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 13 | 0.243 | |
| response to toxic substance | GO:0009636 | 133 | 0.237 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 18 | 0.233 | |
| regulation of metanephric glomerulus development | GO:0072298 | 1 | 0.233 | |
| response to follicle stimulating hormone | GO:0032354 | 18 | 0.230 | |
| negative regulation of apoptotic process | GO:0043066 | 181 | 0.227 | |
| positive regulation of gene expression | GO:0010628 | 244 | 0.225 | Human |
| response to peptide hormone | GO:0043434 | 278 | 0.224 | |
| long term synaptic potentiation | GO:0060291 | 21 | 0.223 | |
| mapk cascade | GO:0000165 | 140 | 0.221 | |
| response to metal ion | GO:0010038 | 253 | 0.218 | |
| regulation of cell differentiation | GO:0045595 | 320 | 0.216 | |
| negative regulation of molecular function | GO:0044092 | 133 | 0.209 | |
| cell morphogenesis involved in neuron differentiation | GO:0048667 | 106 | 0.209 | |
| positive regulation of cellular biosynthetic process | GO:0031328 | 295 | 0.208 | |
| response to amphetamine | GO:0001975 | 25 | 0.205 | |
| regulation of transferase activity | GO:0051338 | 123 | 0.204 | |
| regulation of phosphate metabolic process | GO:0019220 | 349 | 0.204 | |
| cellular response to camp | GO:0071320 | 26 | 0.204 | |
| endocytosis | GO:0006897 | 84 | 0.202 | |
| negative regulation of nucleobase containing compound metabolic process | GO:0045934 | 153 | 0.200 | |
| response to other organism | GO:0051707 | 220 | 0.198 | |
| response to external biotic stimulus | GO:0043207 | 221 | 0.195 | |
| response to radiation | GO:0009314 | 137 | 0.194 | |
| positive regulation of cell proliferation involved in kidney development | GO:1901724 | 4 | 0.192 | |
| heart morphogenesis | GO:0003007 | 3 | 0.187 | |
| protein phosphorylation | GO:0006468 | 345 | 0.186 | |
| response to reactive oxygen species | GO:0000302 | 120 | 0.185 | |
| cytokine mediated signaling pathway | GO:0019221 | 43 | 0.183 | |
| neurological system process | GO:0050877 | 219 | 0.181 | |
| axonogenesis | GO:0007409 | 71 | 0.181 | |
| mrna stabilization | GO:0048255 | 2 | 0.180 | |
| response to corticosteroid | GO:0031960 | 235 | 0.179 | |
| protein sumoylation | GO:0016925 | 4 | 0.178 | |
| regulation of cell proliferation | GO:0042127 | 359 | 0.177 | Human |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 11 | 0.177 | |
| axon development | GO:0061564 | 96 | 0.175 | |
| regulation of glomerular mesangial cell proliferation | GO:0072124 | 4 | 0.175 | |
| embryonic cranial skeleton morphogenesis | GO:0048701 | 2 | 0.175 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 106 | 0.174 | Human |
| regulation of neuron apoptotic process | GO:0043523 | 83 | 0.172 | |
| leukocyte activation | GO:0045321 | 76 | 0.171 | |
| regulation of bmp signaling pathway | GO:0030510 | 2 | 0.169 | |
| response to mycophenolic acid | GO:0071505 | 2 | 0.166 | |
| response to ketone | GO:1901654 | 182 | 0.165 | |
| response to cytokine | GO:0034097 | 215 | 0.162 | |
| response to molecule of bacterial origin | GO:0002237 | 194 | 0.162 | |
| developmental growth | GO:0048589 | 100 | 0.161 | |
| positive regulation of metanephric glomerulus development | GO:0072300 | 1 | 0.157 | |
| negative regulation of gene expression | GO:0010629 | 199 | 0.152 | |
| anatomical structure morphogenesis | GO:0009653 | 298 | 0.150 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 41 | 0.150 | |
| regulation of protein modification process | GO:0031399 | 194 | 0.150 | |
| protein dephosphorylation | GO:0006470 | 38 | 0.148 | |
| positive regulation of cellular catabolic process | GO:0031331 | 71 | 0.147 | Human |
| reproductive process | GO:0022414 | 372 | 0.145 | Rat |
| regeneration | GO:0031099 | 163 | 0.143 | |
| cell cycle | GO:0007049 | 101 | 0.143 | |
| regulation of cell cycle | GO:0051726 | 73 | 0.138 | |
| rna stabilization | GO:0043489 | 2 | 0.134 | |
| wound healing | GO:0042060 | 122 | 0.134 | |
| heart process | GO:0003015 | 57 | 0.132 | |
| response to inorganic substance | GO:0010035 | 377 | 0.132 | |
| cell cycle g2 m phase transition | GO:0044839 | 6 | 0.131 | |
| carbohydrate derivative metabolic process | GO:1901135 | 346 | 0.128 | |
| eye development | GO:0001654 | 50 | 0.126 | |
| regulation of gene expression epigenetic | GO:0040029 | 10 | 0.125 | |
| cellular response to organic cyclic compound | GO:0071407 | 202 | 0.125 | |
| circadian behavior | GO:0048512 | 24 | 0.122 | |
| developmental growth involved in morphogenesis | GO:0060560 | 33 | 0.118 | |
| cellular response to growth factor stimulus | GO:0071363 | 162 | 0.118 | |
| rhythmic process | GO:0048511 | 156 | 0.118 | |
| positive regulation of immune system process | GO:0002684 | 90 | 0.116 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 3 | 0.115 | |
| positive regulation of macromolecule biosynthetic process | GO:0010557 | 247 | 0.112 | |
| organ senescence | GO:0010260 | 2 | 0.111 | |
| negative regulation of biosynthetic process | GO:0009890 | 168 | 0.108 | |
| response to glucocorticoid | GO:0051384 | 223 | 0.106 | |
| regulation of smooth muscle cell proliferation | GO:0048660 | 75 | 0.106 | |
| regulation of kinase activity | GO:0043549 | 117 | 0.104 | |
| cellular response to isoquinoline alkaloid | GO:0071317 | 6 | 0.104 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 120 | 0.103 | |
| regulation of mapk cascade | GO:0043408 | 116 | 0.103 | |
| positive regulation of cell proliferation | GO:0008284 | 249 | 0.099 | |
| connective tissue development | GO:0061448 | 33 | 0.099 | |
| cellular component assembly | GO:0022607 | 360 | 0.097 | |
| multicellular organism reproduction | GO:0032504 | 233 | 0.096 | Rat |
| regulation of phosphorus metabolic process | GO:0051174 | 349 | 0.095 | |
| phagocytosis | GO:0006909 | 17 | 0.094 | |
| cellular response to drug | GO:0035690 | 30 | 0.091 | |
| metanephric glomerular mesangial cell proliferation involved in metanephros development | GO:0072262 | 1 | 0.088 | |
| positive regulation of myeloid leukocyte differentiation | GO:0002763 | 7 | 0.087 | |
| response to isoquinoline alkaloid | GO:0014072 | 28 | 0.087 | |
| organic substance catabolic process | GO:1901575 | 316 | 0.084 | Human |
| circadian rhythm | GO:0007623 | 88 | 0.084 | |
| central nervous system development | GO:0007417 | 311 | 0.082 | |
| g2 m transition of mitotic cell cycle | GO:0000086 | 6 | 0.080 | |
| vasculature development | GO:0001944 | 70 | 0.079 | |
| response to heparin | GO:0071503 | 2 | 0.079 | |
| single organism biosynthetic process | GO:0044711 | 342 | 0.079 | |
| cellular response to cytokine stimulus | GO:0071345 | 127 | 0.079 | |
| response to nutrient levels | GO:0031667 | 370 | 0.078 | |
| aging | GO:0007568 | 241 | 0.077 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 7 | 0.077 | |
| cellular response to insulin stimulus | GO:0032869 | 81 | 0.077 | |
| regulation of programmed cell death | GO:0043067 | 341 | 0.076 | |
| response to mineralocorticoid | GO:0051385 | 49 | 0.075 | |
| humoral immune response | GO:0006959 | 12 | 0.073 | |
| neuron projection development | GO:0031175 | 273 | 0.073 | Human |
| vesicle mediated transport | GO:0016192 | 181 | 0.072 | |
| regulation of protein phosphorylation | GO:0001932 | 183 | 0.072 | |
| immune system development | GO:0002520 | 41 | 0.071 | |
| cellular component biogenesis | GO:0044085 | 368 | 0.070 | |
| wound healing spreading of cells | GO:0044319 | 2 | 0.070 | |
| g0 to g1 transition | GO:0045023 | 4 | 0.070 | |
| carbon catabolite activation of transcription | GO:0045991 | 1 | 0.069 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 80 | 0.069 | |
| heart valve morphogenesis | GO:0003179 | 1 | 0.069 | |
| axon regeneration | GO:0031103 | 28 | 0.069 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 41 | 0.067 | |
| negative regulation of response to stimulus | GO:0048585 | 155 | 0.066 | |
| rhythmic behavior | GO:0007622 | 24 | 0.066 | |
| nucleoside phosphate metabolic process | GO:0006753 | 283 | 0.064 | |
| single organism behavior | GO:0044708 | 130 | 0.064 | |
| mrna 3 end processing | GO:0031124 | 1 | 0.064 | Human |
| negative regulation of neuron death | GO:1901215 | 69 | 0.064 | |
| positive regulation of glomerulus development | GO:0090193 | 4 | 0.063 | |
| positive regulation of cell differentiation | GO:0045597 | 217 | 0.062 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 24 | 0.062 | |
| neuron apoptotic process | GO:0051402 | 88 | 0.062 | |
| single organism carbohydrate metabolic process | GO:0044723 | 118 | 0.061 | |
| response to alkaloid | GO:0043279 | 132 | 0.061 | |
| regulation of cell development | GO:0060284 | 263 | 0.060 | |
| t cell differentiation | GO:0030217 | 9 | 0.060 | |
| glycosyl compound metabolic process | GO:1901657 | 182 | 0.060 | |
| positive regulation of mrna metabolic process | GO:1903313 | 4 | 0.059 | Human |
| chemotaxis | GO:0006935 | 66 | 0.059 | |
| negative regulation of developmental process | GO:0051093 | 125 | 0.059 | |
| learning or memory | GO:0007611 | 90 | 0.058 | |
| negative regulation of multicellular organismal process | GO:0051241 | 203 | 0.058 | |
| locomotory behavior | GO:0007626 | 15 | 0.058 | |
| negative regulation of mapk cascade | GO:0043409 | 20 | 0.058 | |
| cellular response to vascular endothelial growth factor stimulus | GO:0035924 | 6 | 0.057 | |
| neuron differentiation | GO:0030182 | 368 | 0.057 | |
| negative regulation of cell communication | GO:0010648 | 158 | 0.057 | |
| embryonic organ morphogenesis | GO:0048562 | 5 | 0.056 | |
| response to gamma radiation | GO:0010332 | 24 | 0.056 | |
| regulation of neuronal synaptic plasticity | GO:0048168 | 31 | 0.055 | |
| regulation of metanephros development | GO:0072215 | 4 | 0.055 | |
| negative regulation of signal transduction | GO:0009968 | 83 | 0.055 | |
| regulation of rna stability | GO:0043487 | 3 | 0.055 | |
| osteoclast differentiation | GO:0030316 | 11 | 0.054 | |
| developmental process involved in reproduction | GO:0003006 | 159 | 0.054 | |
| cellular response to oxygen containing compound | GO:1901701 | 386 | 0.054 | |
| positive regulation of cardiac muscle contraction | GO:0060452 | 4 | 0.053 | |
| associative learning | GO:0008306 | 19 | 0.053 | |
| viral transcription | GO:0019083 | 2 | 0.053 | |
| feeding behavior | GO:0007631 | 53 | 0.052 | |
| tube development | GO:0035295 | 89 | 0.052 | |
| response to biotic stimulus | GO:0009607 | 226 | 0.051 | |
| sensory organ development | GO:0007423 | 74 | 0.051 | |
| regulation of viral transcription | GO:0046782 | 2 | 0.050 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 36 | 0.049 | |
| response to insulin | GO:0032868 | 133 | 0.049 | |
| immune response | GO:0006955 | 104 | 0.048 | |
| response to mechanical stimulus | GO:0009612 | 134 | 0.048 | |
| regulation of signal transduction | GO:0009966 | 318 | 0.047 | |
| cellular component morphogenesis | GO:0032989 | 155 | 0.047 | |
| response to axon injury | GO:0048678 | 59 | 0.046 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 7 | 0.046 | |
| regulation of protein processing | GO:0070613 | 50 | 0.046 | |
| muscle structure development | GO:0061061 | 87 | 0.046 | |
| negative regulation of protein phosphorylation | GO:0001933 | 44 | 0.046 | |
| multi organism reproductive process | GO:0044703 | 262 | 0.046 | Rat |
| d amino acid transport | GO:0042940 | 1 | 0.046 | |
| negative regulation of catalytic activity | GO:0043086 | 103 | 0.045 | |
| cognition | GO:0050890 | 92 | 0.045 | |
| reproduction | GO:0000003 | 245 | 0.045 | Rat |
| nucleoside phosphate catabolic process | GO:1901292 | 140 | 0.045 | |
| negative regulation of cell differentiation | GO:0045596 | 99 | 0.044 | |
| hemopoiesis | GO:0030097 | 34 | 0.044 | |
| organ regeneration | GO:0031100 | 101 | 0.044 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 122 | 0.044 | |
| regulation of kidney development | GO:0090183 | 15 | 0.044 | |
| cell morphogenesis | GO:0000902 | 142 | 0.044 | |
| regulation of neurogenesis | GO:0050767 | 247 | 0.043 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 91 | 0.043 | |
| negative regulation of cell migration involved in sprouting angiogenesis | GO:0090051 | 1 | 0.043 | |
| regulation of glomerulus development | GO:0090192 | 4 | 0.043 | |
| response to interleukin 1 | GO:0070555 | 55 | 0.042 | |
| mitotic cell cycle phase transition | GO:0044772 | 20 | 0.041 | |
| response to bacterium | GO:0009617 | 200 | 0.041 | |
| negative regulation of protein metabolic process | GO:0051248 | 114 | 0.040 | Human |
| taxis | GO:0042330 | 67 | 0.040 | |
| positive regulation of developmental process | GO:0051094 | 283 | 0.040 | |
| negative regulation of peptidase activity | GO:0010466 | 38 | 0.039 | |
| response to wounding | GO:0009611 | 254 | 0.039 | |
| regulation of intracellular signal transduction | GO:1902531 | 218 | 0.039 | |
| neuron projection regeneration | GO:0031102 | 35 | 0.039 | |
| catabolic process | GO:0009056 | 351 | 0.039 | Human |
| regulation of cellular catabolic process | GO:0031329 | 101 | 0.038 | Human |
| positive regulation of neurogenesis | GO:0050769 | 165 | 0.038 | |
| neuron development | GO:0048666 | 286 | 0.038 | Human |
| facial nerve development | GO:0021561 | 1 | 0.038 | |
| negative regulation of cell development | GO:0010721 | 82 | 0.038 | |
| response to oxidative stress | GO:0006979 | 186 | 0.038 | Rat |
| cell migration involved in sprouting angiogenesis | GO:0002042 | 3 | 0.037 | |
| striated muscle tissue development | GO:0014706 | 58 | 0.037 | |
| positive regulation of response to stimulus | GO:0048584 | 285 | 0.037 | |
| intracellular transport | GO:0046907 | 185 | 0.036 | |
| response to estradiol | GO:0032355 | 164 | 0.036 | |
| localization of cell | GO:0051674 | 202 | 0.036 | |
| response to decreased oxygen levels | GO:0036293 | 237 | 0.035 | |
| response to norepinephrine | GO:0071873 | 5 | 0.035 | |
| purine nucleotide metabolic process | GO:0006163 | 229 | 0.035 | |
| response to cycloheximide | GO:0046898 | 6 | 0.035 | |
| gliogenesis | GO:0042063 | 93 | 0.035 | |
| response to amine | GO:0014075 | 46 | 0.034 | |
| circadian regulation of gene expression | GO:0032922 | 3 | 0.034 | |
| regulation of peptidase activity | GO:0052547 | 55 | 0.032 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 93 | 0.032 | |
| ribonucleotide metabolic process | GO:0009259 | 231 | 0.032 | |
| photoperiodism | GO:0009648 | 4 | 0.032 | |
| cellular response to fatty acid | GO:0071398 | 29 | 0.032 | |
| wound healing spreading of epidermal cells | GO:0035313 | 2 | 0.031 | |
| regulation of nervous system development | GO:0051960 | 264 | 0.031 | |
| immune system process | GO:0002376 | 204 | 0.031 | |
| negative regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043154 | 17 | 0.031 | |
| synapse organization | GO:0050808 | 46 | 0.031 | |
| purine ribonucleotide catabolic process | GO:0009154 | 136 | 0.031 | |
| intracellular signal transduction | GO:0035556 | 314 | 0.031 | |
| response to increased oxygen levels | GO:0036296 | 45 | 0.030 | |
| regulation of phosphorylation | GO:0042325 | 248 | 0.030 | |
| locomotion | GO:0040011 | 237 | 0.030 | |
| growth | GO:0040007 | 165 | 0.030 | |
| positive regulation of catalytic activity | GO:0043085 | 184 | 0.029 | |
| regulation of triglyceride biosynthetic process | GO:0010866 | 4 | 0.029 | |
| nucleoside metabolic process | GO:0009116 | 179 | 0.029 | |
| negative regulation of nf kappab transcription factor activity | GO:0032088 | 4 | 0.029 | |
| placenta development | GO:0001890 | 22 | 0.029 | |
| gamete generation | GO:0007276 | 124 | 0.029 | Rat |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.029 | |
| response to hyperoxia | GO:0055093 | 45 | 0.029 | |
| metanephros development | GO:0001656 | 14 | 0.029 | |
| regulation of catabolic process | GO:0009894 | 113 | 0.029 | Human |
| canonical wnt signaling pathway | GO:0060070 | 9 | 0.029 | |
| response to lipopolysaccharide | GO:0032496 | 191 | 0.029 | |
| synapse assembly | GO:0007416 | 29 | 0.029 | |
| response to transforming growth factor beta | GO:0071559 | 46 | 0.029 | |
| glucose metabolic process | GO:0006006 | 52 | 0.029 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 4 | 0.029 | |
| neuron projection morphogenesis | GO:0048812 | 122 | 0.029 | |
| cell projection organization | GO:0030030 | 302 | 0.028 | Human |
| metanephric nephron development | GO:0072210 | 7 | 0.028 | |
| cell motility | GO:0048870 | 202 | 0.028 | |
| regulation of cell adhesion | GO:0030155 | 52 | 0.028 | |
| positive regulation of metanephros development | GO:0072216 | 2 | 0.028 | |
| cell part morphogenesis | GO:0032990 | 123 | 0.028 | |
| response to estrogen | GO:0043627 | 232 | 0.028 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 119 | 0.028 | |
| response to calcium ion | GO:0051592 | 59 | 0.028 | |
| response to cold | GO:0009409 | 29 | 0.027 | |
| negative regulation of cysteine type endopeptidase activity | GO:2000117 | 18 | 0.027 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 4 | 0.027 | |
| positive regulation of catabolic process | GO:0009896 | 78 | 0.027 | Human |
| response to fibroblast growth factor | GO:0071774 | 29 | 0.027 | |
| cardiovascular system development | GO:0072358 | 134 | 0.027 | |
| organic acid metabolic process | GO:0006082 | 292 | 0.027 | |
| circulatory system process | GO:0003013 | 183 | 0.027 | |
| lipid metabolic process | GO:0006629 | 283 | 0.026 | |
| skeletal muscle tissue development | GO:0007519 | 31 | 0.026 | |
| proteolysis | GO:0006508 | 175 | 0.026 | |
| cell type specific apoptotic process | GO:0097285 | 134 | 0.026 | |
| negative regulation of muscle hyperplasia | GO:0014740 | 1 | 0.026 | |
| response to carbohydrate | GO:0009743 | 183 | 0.025 | |
| embryo development | GO:0009790 | 49 | 0.025 | |
| regulation of vasculature development | GO:1901342 | 44 | 0.025 | |
| positive regulation of cell development | GO:0010720 | 176 | 0.025 | |
| nucleobase containing compound catabolic process | GO:0034655 | 152 | 0.025 | Human |
| positive regulation of neuron death | GO:1901216 | 43 | 0.025 | |
| response to glucose | GO:0009749 | 136 | 0.025 | |
| positive regulation of glomerular metanephric mesangial cell proliferation | GO:0072303 | 1 | 0.025 | |
| erk1 and erk2 cascade | GO:0070371 | 48 | 0.024 | |
| regulation of heart contraction | GO:0008016 | 48 | 0.024 | |
| heart contraction | GO:0060047 | 57 | 0.024 | |
| rhombomere development | GO:0021546 | 1 | 0.024 | |
| response to ammonium ion | GO:0060359 | 71 | 0.023 | |
| amide biosynthetic process | GO:0043604 | 10 | 0.023 | |
| regulation of osteoclast differentiation | GO:0045670 | 8 | 0.023 | |
| rhombomere morphogenesis | GO:0021593 | 1 | 0.023 | |
| glial cell differentiation | GO:0010001 | 65 | 0.023 | |
| cellular response to hydrogen peroxide | GO:0070301 | 42 | 0.023 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 12 | 0.023 | |
| positive regulation of mrna processing | GO:0050685 | 2 | 0.023 | Human |
| regulation of rho gtpase activity | GO:0032319 | 17 | 0.023 | |
| angiogenesis | GO:0001525 | 53 | 0.023 | |
| regulation of heterotypic cell cell adhesion | GO:0034114 | 2 | 0.023 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 83 | 0.023 | |
| positive regulation of phosphorus metabolic process | GO:0010562 | 262 | 0.022 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 84 | 0.022 | |
| response to cocaine | GO:0042220 | 39 | 0.022 | |
| response to carbon dioxide | GO:0010037 | 1 | 0.022 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 38 | 0.022 | |
| cellular component movement | GO:0006928 | 248 | 0.022 | |
| cellular response to abiotic stimulus | GO:0071214 | 85 | 0.022 | |
| positive regulation of molecular function | GO:0044093 | 230 | 0.022 | |
| cellular response to interleukin 1 | GO:0071347 | 37 | 0.022 | |
| regulation of osteoblast proliferation | GO:0033688 | 1 | 0.022 | |
| regulation of cell proliferation involved in kidney development | GO:1901722 | 4 | 0.022 | |
| regulation of ras gtpase activity | GO:0032318 | 32 | 0.022 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 4 | 0.021 | |
| mrna processing | GO:0006397 | 14 | 0.021 | Human |
| rna catabolic process | GO:0006401 | 3 | 0.021 | Human |
| regulation of system process | GO:0044057 | 208 | 0.021 | |
| organic cyclic compound catabolic process | GO:1901361 | 175 | 0.021 | Human |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 72 | 0.021 | |
| sleep | GO:0030431 | 30 | 0.021 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 45 | 0.020 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 167 | 0.020 | |
| cellular response to hypoxia | GO:0071456 | 51 | 0.020 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 31 | 0.020 | |
| axis specification | GO:0009798 | 4 | 0.020 | |
| entrainment of circadian clock | GO:0009649 | 3 | 0.020 | |
| cell migration | GO:0016477 | 197 | 0.020 | |
| regulation of cell projection organization | GO:0031344 | 175 | 0.020 | |
| response to progesterone | GO:0032570 | 48 | 0.020 | |
| multi multicellular organism process | GO:0044706 | 138 | 0.020 | |
| negative regulation of transferase activity | GO:0051348 | 29 | 0.020 | |
| natural killer cell mediated immune response to tumor cell | GO:0002423 | 1 | 0.020 | |
| response to morphine | GO:0043278 | 27 | 0.020 | |
| regulation of metal ion transport | GO:0010959 | 118 | 0.019 | |
| gtp catabolic process | GO:0006184 | 71 | 0.019 | |
| negative regulation of cell proliferation | GO:0008285 | 119 | 0.019 | Human |
| nucleotide metabolic process | GO:0009117 | 279 | 0.019 | |
| dephosphorylation | GO:0016311 | 98 | 0.019 | |
| monosaccharide metabolic process | GO:0005996 | 61 | 0.019 | |
| response to anoxia | GO:0034059 | 4 | 0.019 | |
| regulation of nucleotide catabolic process | GO:0030811 | 65 | 0.019 | |
| cellular response to peptide | GO:1901653 | 133 | 0.019 | |
| regulation of cyclin dependent protein serine threonine kinase activity | GO:0000079 | 3 | 0.019 | |
| cardiac ventricle development | GO:0003231 | 1 | 0.019 | |
| positive regulation of cellular protein metabolic process | GO:0032270 | 167 | 0.019 | |
| negative regulation of osteoblast differentiation | GO:0045668 | 2 | 0.018 | |
| skeletal muscle organ development | GO:0060538 | 33 | 0.018 | |
| purine ribonucleotide metabolic process | GO:0009150 | 227 | 0.018 | |
| cell cycle phase transition | GO:0044770 | 21 | 0.018 | |
| positive regulation of ossification | GO:0045778 | 17 | 0.018 | |
| response to gonadotropin | GO:0034698 | 34 | 0.018 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 115 | 0.018 | |
| single organism intracellular transport | GO:1902582 | 166 | 0.018 | |
| purine nucleotide catabolic process | GO:0006195 | 136 | 0.018 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 37 | 0.017 | Human |
| ossification | GO:0001503 | 70 | 0.017 | |
| muscle organ development | GO:0007517 | 50 | 0.017 | |
| cell cycle process | GO:0022402 | 57 | 0.017 | |
| protein processing | GO:0016485 | 68 | 0.017 | |
| ribose phosphate metabolic process | GO:0019693 | 235 | 0.017 | |
| negative regulation of response to biotic stimulus | GO:0002832 | 4 | 0.017 | |
| skeletal system development | GO:0001501 | 41 | 0.017 | |
| regulation of gliogenesis | GO:0014013 | 39 | 0.017 | |
| negative regulation of protein modification process | GO:0031400 | 52 | 0.017 | |
| mitotic cell cycle | GO:0000278 | 49 | 0.017 | |
| regulation of ossification | GO:0030278 | 32 | 0.017 | |
| embryonic placenta development | GO:0001892 | 1 | 0.017 | |
| negative regulation of signaling | GO:0023057 | 157 | 0.016 | |
| carbohydrate metabolic process | GO:0005975 | 130 | 0.016 | |
| regulation of dna metabolic process | GO:0051052 | 60 | 0.016 | |
| metanephric glomerular mesangium development | GO:0072223 | 1 | 0.016 | |
| sexual reproduction | GO:0019953 | 148 | 0.016 | Rat |
| hindbrain morphogenesis | GO:0021575 | 2 | 0.016 | |
| regulation of immune system process | GO:0002682 | 123 | 0.016 | |
| regulation of neuron projection development | GO:0010975 | 161 | 0.016 | |
| heart valve development | GO:0003170 | 1 | 0.016 | |
| positive regulation of nervous system development | GO:0051962 | 178 | 0.015 | |
| organ morphogenesis | GO:0009887 | 75 | 0.015 | |
| epiboly involved in wound healing | GO:0090505 | 2 | 0.015 | |
| myelination | GO:0042552 | 39 | 0.015 | |
| epithelium migration | GO:0090132 | 19 | 0.015 | |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 6 | 0.015 | |
| fibrinolysis | GO:0042730 | 2 | 0.015 | |
| epiboly | GO:0090504 | 2 | 0.015 | |
| skeletal muscle satellite cell proliferation | GO:0014841 | 1 | 0.015 | |
| cellular response to extracellular stimulus | GO:0031668 | 73 | 0.015 | |
| cholesterol efflux | GO:0033344 | 1 | 0.015 | |
| negative regulation of cellular response to insulin stimulus | GO:1900077 | 11 | 0.015 | |
| signal transduction by phosphorylation | GO:0023014 | 144 | 0.015 | |
| head development | GO:0060322 | 247 | 0.015 | |
| purine containing compound metabolic process | GO:0072521 | 253 | 0.015 | |
| macromolecule localization | GO:0033036 | 252 | 0.015 | |
| cellular ketone metabolic process | GO:0042180 | 51 | 0.015 | |
| response to fatty acid | GO:0070542 | 65 | 0.014 | |
| positive regulation of humoral immune response | GO:0002922 | 2 | 0.014 | |
| endothelial cell migration | GO:0043542 | 9 | 0.014 | |
| hair cell differentiation | GO:0035315 | 2 | 0.014 | |
| cardiac chamber development | GO:0003205 | 1 | 0.014 | |
| cellular response to acid chemical | GO:0071229 | 75 | 0.014 | |
| cell activation | GO:0001775 | 97 | 0.014 | |
| epithelium development | GO:0060429 | 96 | 0.014 | |
